Cargando…

Work Sustainability Among Male Cancer Survivors After Returning to Work

BACKGROUND: Few studies have investigated the work continuance rate among cancer survivors after return to work (RTW). The objective of this study was to clarify work sustainability after RTW among Japanese male cancer survivors. METHODS: We collected data on male cancer survivors from an occupation...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Motoki, Haruyama, Yasuo, Muto, Go, Kiyohara, Kosuke, Mizoue, Tetsuya, Kojimahara, Noriko, Yamaguchi, Naohito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Epidemiological Association 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800885/
https://www.ncbi.nlm.nih.gov/pubmed/29093353
http://dx.doi.org/10.2188/jea.JE20160152
Descripción
Sumario:BACKGROUND: Few studies have investigated the work continuance rate among cancer survivors after return to work (RTW). The objective of this study was to clarify work sustainability after RTW among Japanese male cancer survivors. METHODS: We collected data on male cancer survivors from an occupational health register. Inclusion criteria were as follows: employees who returned to work after an episode of sick leave due to clinically certified cancer diagnosed between January 1, 2000 and December 31, 2011. RESULTS: Of 1,033 male employees who were diagnosed with cancer, 786 employees (76.1%) returned to work after their first episode of sick leave due to cancer. Work continuance rates among all subjects were 80.1% 1 year after RTW and 48.5% 5 years after RTW. The mean duration of work after RTW was 4.5 years. The work continuance rates varied significantly by cancer type. The “Lung” and “Hepatic, Pancreatic” cancer groups had the shortest duration of work (0.9 year after RTW). CONCLUSIONS: Of workers who returned to work after their first episode of leave after cancer, 50% continued to work after 5 years in large-scale companies. There was a steep decrease in work continuance rates during the first year after RTW, with considerable differences according to cancer site.